it is called esophageal cancer or cancer of the esophagus. A cancerous tumor can develop at any point along the esophagus.

BeiGene (NASDAQ:ONC) announced Tuesday that the U.S. Food and Drug Administration (FDA) approved its anti-tumor agent Tevimbra as a first-line therapy for certain patients with esophageal cancer as ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet ...

In participants with a PD-L1 Tumor Area Positivity of at least ... Tevimbra is also indicated for esophageal cancer as monotherapy in adults with unresectable or metastatic ESCC after prior ...

Prof. Gaofeng Liang from Clinical Medical College and Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan University of Science and Technology Disclaimer ...

Cancers of the esophagus are uniquely challenging to treat, for two important reasons. First, esophageal cancers are relatively uncommon in the United States, and thus many clinicians will not have ...

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy as first-line treatment for unresectable or metastatic, PD-L1-positive ESCC.